Karin Nelander

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Placebo Controlled

Chronic Obstructive Pulmonary Disease

Tyrosine Kinase

Heart Rate Variability

Top Venues

Pharmacology research & perspectives

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Karin Nelander, Maria Lagerstrom-Fermer, Carl Amilon, Erik Michaëlsson, Maria Heijer, Magnus Kjaer, Muir Russell, David Han, Eva-Lotte Lindstedt, Carl Whatling, Li-Ming Gan, Hans Ericsson
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction. Clinical and translational science 14 (3) (2021)